Parameters | Grading progress | Healthy cases | Bilharzial bladder cancerous patients | non-bilharzial bladder cancerous patients | ||||
---|---|---|---|---|---|---|---|---|
 |  |  | I | II | III | I | II | III |
 |  | n = 10 | n = 4 | n = 5 | n = 6 | n = 6 | n = 4 | n = 5 |
AST (U/L) | Mean ± S.D | 28.4 ± 2.3 | 102.7 ± 6.9 | 120.6 ± 8.5 | 132.9 ± 10.1 | 85.3 ± 4.9 | 96.5 ± 9.3 | 107.3 ± 11.6 |
 | P < | -- | H.S | H.S | H.S | H.S | H.S | H.S |
ALT (U/L) | Mean ± S.D | 26.3 ± 1.8 | 82.2 ± 3.95 | 96.5 ± 6.1 | 111.1 ± 9.9 | 69.3 ± 6.5 | 83.3 ± 7.6 | 99.8 ± 6.7 |
 | P< | -- | H.S | H.S | H.S | H.S | H.S | H.S |
LDH (U/L) | Mean ± S.D | 139.9 ± 13.8 | 351.5 ± 20.2 | 434.7 ± 21.4 | 489.3 ± 37.6 | 334.4 ± 15.5 | 379.1 ± 14.2 | 408.6 ± 14.2 |
 | P< | -- | H.S | H.S | H.S | H.S | H.S | H.S |
Total protein gm% | Mean ± S.D | 7.7 ± 0.5 | 8.30 ± 0.6 | 8.40 ± 0.4 | 9.30 ± 0.3 | 7.40 ± 0.3 | 7.5 ± 0.4 | 7.80 + 0.5 |
 | P < | -- | S | S | S | N.S | N.S | N.S |